MONONUCLEAR PHAGOCYTE-DERIVED GROWTH FACTOR
MONONUCLEAR PHAGOCYTE-DERIVED GROWTH FACTOR
批准号:
3169262
负责人:
G. YANCEY GILLESPIE
金额:
$11.7万
依托单位国家:
美国
项目类别:
财政年份:
1981
资助国家:
美国
项目状态:
已结题
起止时间:
1981-08-01 至 1987-05-31
关键词:
affinity chromatography cell differentiation cell growth regulation cell population study cell sorting epidermal growth factor fibroblast growth factor gel electrophoresis gene expression high performance liquid chromatography hybridomas inflammation macrophage macrophage activating factor membrane activity molecular cloning monoclonal antibody monocyte monokines neoplastic transformation phagocytes radioimmunoassay radiotracer tissue /cell culture wound healing
中文摘要
这项研究的目标是发展我们对
单核巨噬细胞调控增殖的基本机制(S)
各种正常细胞类型。到目前为止,我们的发现表明
巨噬细胞和巨噬细胞样细胞系阐述特异的可溶性
可导致静止的成纤维细胞启动横跨血管的因子(S)
细胞周期。在操作上,这个独角兽(S)是一个“能力”因素,
其作用类似于其他已知的活性因子(血小板源
生长因子和成纤维细胞生长因子),但在生化上与
两者都有。我们集中力量净化空气中的
人巨噬细胞衍生能力因子(MDCF)
培养的P388D1,一种小鼠巨噬细胞样细胞系,阐述了慷慨的
除另一种生长因子白介素1(IL-1)外,还需补充一定数量的MDCF。
我们通过使P388D1细胞生长来极大地简化了纯化
在规定的介质中连续无血清。的串口应用
超滤、凝胶过滤和离子交换层析
在生化/生物物理方面明确分离的MDCF和IL-1
性质和生物活性。银染十二烷基硫酸钠-PAGE分析
平板凝胶显示了与MDCF相对应的两条主要蛋白质条带
活性和与IL-1活性相对应的一个。的配套研究
亲和纯化的IL-1证实了我们的发现,MDCF和IL-1是不同的
生化和生物实体。使用这个大大提纯的MDCF,我们
现在开始用兔子和单抗研制出特异的抗血清
用大鼠-小鼠杂交瘤抗体鉴定和定量mdcf
体内和体外实验。我们的目标是将这只独角兽与
其他已知的生长因子,作为使用这些因子作为探针的第一步
剖析与增殖相关的细胞事件。结果是
所获得的结果应为明确研究两者之间的关系奠定基础
体内巨噬细胞衍生能力因子的产生对损伤的影响
以单核巨噬细胞堆积,广泛纤维增生为特征,
和胶原蛋白沉积。(J)
英文摘要
The goal of this research is to develop our fundamental knowledge of the
basic mechanism(s) by which mononuclear phagocytes regulate proliferation
of various normal cell types. Our findings to date suggest that
macrophages and macrophage-like cell lines elaborate specific soluble
factor(s) that can cause quiescent fibroblasts to initiate traverse of the
cell cycle. Operationally, this monokine(s) is a "competence" factor,
similar in its action to other known competence factors (platelet-derived
growth factor and fibroblast growth factor) but biochemically distinct from
both. We have concentrated our efforts on purification of the
macrophage-derived competence factor (MDCF) from spent supernates of
cultured P388D1, a mouse macrophage-like cell line that elaborates generous
amounts of MDCF in addition to another growth factor, interleukin-1 (IL-1).
We have greatly simplified purification by adapting P388D1 cells to grow
continuously serum-free in a defined medium. Serial application of
ultrafiltration, gel filtration, and ion exchange chromatography has
clearly separated MDCF and IL-1, both in terms of biochemical/biophysical
properties and biological activities. Analysis by silver-stained SDS-PAGE
slab gels reveals two major bands of protein that correspond to MDCF
activity and one that corresponds to IL-1 activity. Companion studies of
affinity-purified IL-1 confirm our findings that MDCF and IL-1 are distinct
biochemical and biological entities. Using this greatly purified MDCF, we
are now beginning to develop specific antisera using rabbits and monoclonal
antibodies using rat-mouse hybridomas to identify and quantify MDCF for in
vivo and in vitro experiments. Our aim is to compare this monokine with
other known growth factors as an initial step in using these as probes to
dissect the cellular events associated with proliferation. The results
obtained should provide a foundation for definitive studies on the relation
of macrophage-derived competence factor production in vivo to lesions
characterized by mononuclear phagocyte accumulation, extensive fibroplasia,
and collagen deposition. (J)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Glioblastoma tumor microenvironmental influence on acquired and inherent cancer therapy resistance.
-
批准号:10046398
-
项目类别:
-
资助金额:$29.77万
-
财政年份:2018
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
A Phase 1 Study of M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma.
-
批准号:9455636
-
项目类别:
-
资助金额:$55.93万
-
财政年份:2017
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
Experimental Glioma Animal Models Core
-
批准号:8299607
-
项目类别:
-
资助金额:$17.54万
-
财政年份:2011
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
CONTEMPORARY THERAPEUTICS FOR ANAPLASTIC GLIOMAS
-
批准号:8540977
-
项目类别:
-
资助金额:$70.0万
-
财政年份:2011
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
CONTEMPORARY THERAPEUTICS FOR ANAPLASTIC GLIOMAS
-
批准号:8337752
-
项目类别:
-
资助金额:$70.0万
-
财政年份:2011
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
CONTEMPORARY THERAPEUTICS FOR ANAPLASTIC GLIOMAS
-
批准号:8147551
-
项目类别:
-
资助金额:$90.0万
-
财政年份:2011
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
Molecular Therapeutics for Anaplastic Gliomas
-
批准号:7908624
-
项目类别:
-
资助金额:$24.64万
-
财政年份:2009
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
Experimental Glioma Animal Models Core
-
批准号:7747240
-
项目类别:
-
资助金额:$18.02万
-
财政年份:2009
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
Molecular Therapeutics for Anaplastic Gliomas
-
批准号:7454560
-
项目类别:
-
资助金额:$107.3万
-
财政年份:2002
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
Molecular Therapeutics for Anaplastic Gliomas
-
批准号:7253509
-
项目类别:
-
资助金额:$12.48万
-
财政年份:2002
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
Molecular Therapeutics for Anaplastic Gliomas
-
批准号:6772544
-
项目类别:
-
资助金额:$233.77万
-
财政年份:2002
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
Molecular Therapeutics for Anaplastic Gliomas
-
批准号:7848492
-
项目类别:
-
资助金额:$23.31万
-
财政年份:2002
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
Molecular Therapeutics for Anaplastic Gliomas
-
批准号:7117060
-
项目类别:
-
资助金额:$10.36万
-
财政年份:2002
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
Molecular Therapeutics for Anaplastic Gliomas
-
批准号:6919955
-
项目类别:
-
资助金额:$234.39万
-
财政年份:2002
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
Molecular Therapeutics for Anaplastic Gliomas
-
批准号:7463018
-
项目类别:
-
资助金额:$12.93万
-
财政年份:2002
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
Molecular Therapeutics for Anaplastic Gliomas
-
批准号:7077704
-
项目类别:
-
资助金额:$233.14万
-
财政年份:2002
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
CORE--EXPERIMENTAL GLIOMA TISSUE FACILITY
-
批准号:6502919
-
项目类别:
-
资助金额:$20.68万
-
财政年份:2001
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
CORE--EXPERIMENTAL GLIOMA TISSUE FACILITY
-
批准号:6324642
-
项目类别:
-
资助金额:$21.52万
-
财政年份:2000
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
CORE--EXPERIMENTAL GLIOMA TISSUE FACILITY
-
批准号:6103256
-
项目类别:
-
资助金额:$21.52万
-
财政年份:1999
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
CORE--EXPERIMENTAL GLIOMA TISSUE FACILITY
-
批准号:6269783
-
项目类别:
-
资助金额:$19.95万
-
财政年份:1998
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
海外基金